SAB Biotherapeutics
SABS
SABS
41 hedge funds and large institutions have $93.6M invested in SAB Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.13M | |
| 2 | +$2.02M | |
| 3 | +$2.01M | |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$1.86M |
| 5 |
Millennium Management
New York
|
+$1.56M |
Top Sellers
| 1 | -$5.19M | |
| 2 | -$3.98M | |
| 3 | -$2.49M | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.35M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$1.01M |